Healthcare Technology Management (HTM): 2026 Statutory Standards and Professional Governance

By Professor John Sandham CEng FIHEEM

In the modern NHS, the definition of a "medical device" has expanded far beyond the bedside. From AI-driven diagnostic software to complex robotic surgical systems and remote patient monitoring arrays, NHS Trusts are managing an ever-widening volume and variety of healthcare technology. This proliferation brings immense clinical benefits but also unprecedented pressures on governance, interoperability, and safety.

Effective management is no longer merely a technical support function; it is a critical pillar of clinical service delivery. As we navigate the regulatory landscape of 2026, the transition from provider-centric models to system-wide accountability under the Health and Care Act 2022 has fundamentally redefined how Trusts must approach technology lifecycle management.

1. Introduction

The modern NHS manages an increasingly diverse and complex medical technology estate. Regulatory and statutory frameworks emphasise that safe and effective HTM is central to patient safety and clinical quality (MHRA, 2021; CQC, 2024). Providers are expected to demonstrate lifecycle management across commissioning, maintenance, and decommissioning, with digital systems increasingly facilitating evidence provision during inspection.

2. Statutory Basis

Regulation 15 of the Health and Social Care Act 2008 (Regulated Activities) Regulations 2014 mandates that all equipment used in care delivery must be clean, secure, suitable for its intended purpose, and maintained in accordance with manufacturer guidance (CQC, 2024). Integrated Care Boards (ICBs), established under the Health and Care Act 2022, provide strategic system oversight; however, individual NHS Trusts retain legal responsibility for equipment safety and compliance (Department of Health and Social Care, 2022). Accountability cannot be delegated to external contractors.

3. Regulatory Landscape

3.1 Post-Market Surveillance

The Medical Devices (Post-Market Surveillance – Great Britain) Regulations 2024 require Trusts to support vigilance systems and trend analysis of adverse events (MHRA, 2021). Serious incidents must be reported within defined regulatory timeframes, enabling early intervention to mitigate patient harm.

3.2 CE and UKCA Marking

Following consultation in 2026, the MHRA signalled continued recognition of CE-marked devices for use in Great Britain, ensuring stability for procurement while transitioning to a UK-specific regulatory framework (MHRA, 2026). Legacy devices remain compliant until at least 31 December 2028.

4. CQC Assessment and Inspection

The Care Quality Commission’s Single Assessment Framework focuses on “Safe” and “Well-led” domains. Providers are expected to maintain auditable systems covering commissioning, calibration, maintenance, and decommissioning (CQC, 2024). Digital asset management systems are increasingly regarded as best practice, improving accessibility and verifiability of records. Deficiencies in equipment governance may adversely affect inspection outcomes.

5. Governance and Clinical Responsibility

5.1 Medical Device Safety Officer

Each NHS Trust must appoint a Medical Device Safety Officer (MDSO) to act as the primary link between clinical engineering, regulatory reporting, and frontline operations. The MDSO coordinates responses to safety alerts, recalls, and national patient safety guidance (MHRA, 2021).

5.2 Workforce Competency

Staff training and competence must align with Regulation 18 requirements, ensuring safe use of Software as a Medical Device (SaMD) and AI-enabled systems. Competency assessments should reflect the risks associated with algorithmic outputs and digital interfaces (CQC, 2024).

6. Conclusion

Healthcare technology management is a critical pillar of patient safety and service quality. While digital systems are not yet mandated, they are becoming operationally essential for demonstrating compliance. Strategic integration of HTM into organisational governance ensures that Trusts can meet statutory, regulatory, and inspection expectations in an increasingly complex technological landscape.

References

Care Quality Commission (2024) Regulation 15: Premises and equipment. 2026 Framework Guidance. London: CQC.

Department of Health and Social Care (2022) Health and Care Act 2022. London: HMSO.

MHRA (2021) Managing Medical Devices: Guidance for healthcare and social services organisations. London: MHRA.

MHRA (2026) Consultation on indefinite recognition of CE-marked medical devices in Great Britain. London: MHRA.

Medical Devices (Post-Market Surveillance – Great Britain) Regulations 2024. London: HMSO.